510(k) device
Trivex System
Smith & Nephew, Inc. · Stripper, Vein, External (DWQ, Class II) · First FDA decision Oct 29, 2003, newest Oct 29, 2003Varicose veins and venous insufficiency
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Trivex"
MAUDE reports
78
Brand "Trivex", since 2015
PubMed studies
22
Mentioning "Trivex"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Trivex System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TRIVEX SYSTEM510(k)
K032387 · Decided Oct 29, 2003 · 86 days after receipt
Device type: Stripper, Vein, External (DWQ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Trivex", any status and sponsor, newest update first.
No registered device study names "Trivex".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trivex", and for the whole product code for context.
This brand
78 reports: 78 malfunction, 0 injury, 0 death
Whole product code DWQ
87 reports: 87 malfunction, 0 injury, 0 death
Newest reports for this brand
- MDU, TRIVEXMalfunction
1643264-2024-00067 · Received Jan 30, 2024 · Event dated Jun 7, 2023
Device type: Saw, Powered, And Accessories (HAB)
Device problem as coded: Overheating of Device; Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Smith & Nephew, Inc Endoscopy Division
Z-1105-2007 · Started Oct 12, 2004 · Posted by FDA Aug 2, 2007
Reason given: Build-up of static charge in Pneumatic Footswitch tubing may cause control unit to reset to default settings in the operating room during surgery.
Cause as FDA categorized it: Other · Device type: Stripper, Vein, External (DWQ)
Published research
The most relevant PubMed records for "Trivex"[tiab]. The summary above synthesizes these.
- Prospective randomized controlled trial: conventional versus powered phlebectomy.
Aremu MA, Mahendran B, Butcher W, et al. · J Vasc Surg · 2004Clinical Trial, Comparative Study
- Application of the Trivex system in the treatment of primary severe superficial varicose veins of the lower extremity.
Yu W, Liu J, Yang H, et al. · J Interv Med · 2019
- [Clinical analysis on treatment for superficial varicosities of low limbs with minimally invasive rotary varicotomy].
Zhang WD, Yuan C, Xing T, et al. · Zhonghua Wai Ke Za Zhi · 2006English Abstract
- A Monte Carlo simulation study on the evaluation of radiation protection properties of spectacle lens materials.
Bilici S, Kamislioglu M, Altunsoy Guclu EE · Eur Phys J Plus · 2023
- Removal of Benign Superficial Masses Using the TriVex System: Preliminary Clinical Results.
Duan SJ, Jiang RZ, Zhang YX, et al. · Surg Innov · 2018
- Transilluminated powered mini-phlebectomy: early clinical experience.
Scavée V, Theys S, Schoevaerdts JC · Acta Chir Belg · 2001Clinical Trial
- [Experience of endovenous radiofrequency combined with TriVex in treatment of chronic venous insufficiency in lower extremity].
Lin SM, Zhang ZH, Yao YD, et al. · Zhonghua Wai Ke Za Zhi · 2009English Abstract, Randomized Controlled Trial
- Transilluminated powered phlebectomy: a clinical report.
Akesson H · Phlebology · 2008
- Transilluminated powered phlebectomy: advantages and disadvantages of a new technique.
Shamiyeh A, Schrenk P, Huber E, et al. · Dermatol Surg · 2003Clinical Trial, Research Support, Non-U.S. Gov't
- Efficacy and safety of short-term rivaroxaban prophylaxis after radiofrequency ablation for varicose veins: A single-centre randomised controlled trial.
Zhang T, Ge X, Ye P, et al. · Phlebology · 2026Randomized Controlled Trial
- Ultrasound-guided TriVexࡊ-powered phlebectomy for debulking of peripheral vascular anomalies - A novel treatment technique.
Parsi K, Kang M, Trimboli A · Phlebology · 2019Case Reports
- Transilluminated powered phlebectomy in the treatment of large area venous leg ulcers: A case-control study with 3 years follow-up.
Chen S, Zeng Q, Fu Q, et al. · Microcirculation · 2019Clinical Trial, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code DWQ.
- PhasTIPPLeMaitre Vascular, Inc. · 510(k) 2022
- Smith & Nephew Tumescent Catheter Inversion System, Model 7210023Smith & Nephew, Inc. · 510(k) 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.